Jeffrey Del - Aug 9, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Commercial Officer
Signature
/s/ Jeffrey Del Carmen
Stock symbol
CPRX
Transactions as of
Aug 9, 2024
Transactions value $
-$578,510
Form type
4
Date filed
8/13/2024, 05:01 PM
Previous filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale -$112K -6.06K -32.88% $18.44 12.4K Aug 9, 2024 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $85.8K +30K +242.54% $2.86 42.4K Aug 9, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$553K -30K -70.81% $18.42 12.4K Aug 9, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -30K -3.6% $0.00 804K Aug 9, 2024 Common Stock 30K $2.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Shares were sold in various lots from $18.33 to $18.48 per share. The price listed represents a weighted average price for the shares sold.
F3 Shares vested in five annual tranches beginning on August 6, 2019.